Cheshire, United Kingdom

Stuart Corr

USPTO Granted Patents = 48 

 

 

Average Co-Inventor Count = 2.3

ph-index = 9

Forward Citations = 215(Granted Patents)


Location History:

  • Appleton, GB (1999 - 2007)
  • Runcorn, GB (2001 - 2020)
  • Cheshire, GB (2000 - 2023)
  • Warrington, GB (2000 - 2024)

Company Filing History:


Years Active: 1999-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Pharmaceutical Composition
Salbutamol Sulphate
Gas Stream Drying
Propellant Filling Apparatus
Heat Transfer Compositions
Enzymatic Process
Solvent Recovery
Fluoromethyl Hexafluoroisopropyl Ether
Lubricant Compositions
Refrigerant Compositions
Closed Cell Polymer Foam
Biomass Extraction
48 patents (USPTO):Explore Patents

Title: Innovations and Patents of Stuart Corr

Introduction: Stuart Corr is a notable inventor based in Cheshire, GB, with an impressive portfolio of 48 patents. His work primarily focuses on pharmaceutical compositions, contributing to advancements in medical technology and drug delivery systems.

Latest Patents: Among his latest innovations, Stuart has developed two significant pharmaceutical compositions. The first composition features a drug component consisting of salmeterol xinafoate and fluticasone propionate, combined with a propellant component that contains at least 90 wt % of 1,1-difluoroethane (HFA-152a). The second composition may include a drug component alongside another propellant, with the drug component comprising pharmaceutically acceptable salts of glycopyrrolate, budesonide, and a long-acting beta-2-agonist (LABA) such as formoterol and its salts, also utilizing 1,1-difluoroethane (HFA-152a) as the propellant.

Career Highlights: Stuart has made significant contributions to the field of pharmaceuticals through his innovative research and development efforts. His experience includes work with prominent companies, such as Mexichem Fluor and Ineos Fluor Holdings Limited, where he played a key role in the formulation and development of new drug delivery systems.

Collaborations: Throughout his career, Stuart has collaborated with distinguished individuals in the industry, including Timothy James Noakes and Robert E. Low. These collaborations have allowed for a rich exchange of ideas and expertise, enhancing his impact on pharmaceutical innovations.

Conclusion: Stuart Corr exemplifies the spirit of innovation in the pharmaceutical industry. With his remarkable track record of 48 patents and ongoing contributions to drug development, he continues to make strides in enhancing healthcare solutions. As he progresses in his career, the impact of his inventions will undoubtedly be felt in the medical community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…